CIK 0001730430
- Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981795578
- Phone
- +1 781-431-9100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Planned sale CHIEF MEDICAL OFFICER sold 400 shares at $17.53 ($7,012)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 29,000 shares at an average $19.14 ($555,160)
- 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
- 4 Grant or award Director acquired 17,492 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 291 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 1,155 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 1,353 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 734 shares (to pay taxes)
- 4 Shares withheld for taxes CHAIRMAN & CEO gave up 2,933 shares (to pay taxes)
Page 11 of 20 · 386 filings